Cesar Y. Guerrero-Miranda M.D.

Posted February 20th 2022

Importance of right heart catheterization in advanced heart failure management.

Cesar Y. Guerrero-Miranda, M.D.

Cesar Y. Guerrero-Miranda, M.D.

Cochran, J. M., Alam, A. and Guerrero-Miranda, C. Y. (2022). “Importance of right heart catheterization in advanced heart failure management.” Rev Cardiovasc Med 23(1): 12.

Full text of this article.

Patients with chronic congestive heart failure belong to a population with reduced quality of life, poor functional class, and increased risk of mortality and morbidity. In these patients, assessment of invasive hemodynamics both serves therapeutic purposes and is useful for stratification roles. The right heart catheterization has become a cornerstone diagnostic tool for patients in refractory heart failure or cardiogenic shock, as well as for the assessment of candidacy for heart replacement therapies, and the management of patients following mechanical circulatory assist device implantation and heart transplantation.


Posted November 30th 2020

The COVID-19 pandemic: A community approach.

Cesar Y. Guerrero-Miranda, M.D.

Cesar Y. Guerrero-Miranda, M.D.

Cravedi, P., Schold, J.D., Safa, K., Kates, O.S., Elfadawy, N., Mannon, R.B., Shah, M.B., Hammond, S.P., Avery, R., Guerrero Miranda, C., Riella, L.V., Jowsey-Gregoire, S., Akalin, E., Camirand, G., Alegre, M.L. and Azzi, J. (2020). “The COVID-19 pandemic: A community approach.” Clin Transplant 34(11): e14059.

Full text of this article.

An unprecedented global pandemic caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has quickly overwhelmed the health care systems worldwide. While there is an absence of consensus among the community in how to manage solid organ transplant recipients and donors, a platform provided by the American Society of Transplantation online community “Outstanding Questions in Transplantation,” hosted a collaborative multicenter, multinational discussions to share knowledge in a rapidly evolving global situation. Here, we present a summary of the discussion in addition to the latest published literature.


Posted September 20th 2020

The COVID-19 Pandemic: A community approach.

Cesar Y. Guerrero-Miranda, M.D.

Cesar Y. Guerrero-Miranda, M.D.

Cravedi, P., Schold, J.D., Safa, K., Kates, O.S., Elfadawy, N., Mannon, R.B., Shah, M.B., Hammond, S.P., Avery, R., Guerrero Miranda, C., Riella, L.V., Jowsey-Gregoire, S., Akalin, E., Camirand, G., Alegre, M.L. and Azzi, J. (2020). “The COVID-19 Pandemic: A community approach.” Clin Transplant Aug 6;e14059. [Epub ahead of print.].

Full text of this article.

An unprecedented global pandemic caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has quickly overwhelmed the health care systems worldwide. While there is an absence of consensus among the community in how to manage solid organ transplant recipients and donors, a platform provided by the American Society of Transplantation online community “Outstanding Questions in Transplantation”, hosted a collaborative multicenter, multinational discussions to share knowledge in a rapidly evolving global situation. Here, we present a summary of the discussion in addition to the latest published literature


Posted August 15th 2020

Rethinking the Future with Evolving Technology: It’s Time to Empower Change in Heart Transplantation.

Cesar Y. Guerrero-Miranda, M.D.

Cesar Y. Guerrero-Miranda, M.D.

Guerrero-Miranda, C. Y. and S. A. Hall (2020). “Rethinking the Future with Evolving Technology: It’s Time to Empower Change in Heart Transplantation.” Am J Transplant 2020 Jul 27. [Epub ahead of print.].

Full text of this article.

According to the National Institutes of Health (NIH) Biomarker Definition Working Group, biomarkers are characteristics objectively measured and indicators of a physiologic or pathologic process. In 1847, the first cancer biomarker was discovered when the Bence Jones proteins were found in the urine of patients with Multiple Myeloma; since then, biomarkers have played a crucial role in modern medicine. An ideal biomarker should be non-invasive, low cost, quantifiable, consistent across ethnic and gender groups, and reflect correlation in different diseases or conditions.


Posted June 24th 2020

Recognizing Right Ventricular Dysfunction in Coronavirus Disease-2019-Related Respiratory Illness.

Gregory P. Milligan, M.D.

Gregory P. Milligan, M.D.

Milligan, G. P., A. Alam and C. Guerrero-Miranda (2020). “Recognizing Right Ventricular Dysfunction in Coronavirus Disease-2019-Related Respiratory Illness.” J Card Fail May 11;S1071-9164(20)30497-8. [Epub ahead of print].

Full text of this article.

We have read the article by Tersalvi and colleagues1 detailing mechanisms of elevated troponin in patients with coronavirus disease 2019 (COVID-19), and we write to encourage recognition of acute right ventricular (RV) strain as an additional possibility. [No abstract; excerpt from article].